Atlanta Capital Management Co. L L C reduced its stake in Steris PLC (NYSE:STE) by 1.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 426,171 shares of the medical equipment provider’s stock after selling 5,343 shares during the quarter. Atlanta Capital Management Co. L L C owned 0.50% of Steris worth $37,674,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Janus Henderson Group PLC lifted its holdings in shares of Steris by 1,972.4% in the 2nd quarter. Janus Henderson Group PLC now owns 7,679,507 shares of the medical equipment provider’s stock worth $625,880,000 after acquiring an additional 7,308,950 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Steris by 33.4% in the 2nd quarter. BlackRock Inc. now owns 7,032,984 shares of the medical equipment provider’s stock worth $573,188,000 after acquiring an additional 1,760,879 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Steris by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 6,879,760 shares of the medical equipment provider’s stock worth $560,700,000 after acquiring an additional 107,644 shares during the last quarter. FMR LLC lifted its holdings in shares of Steris by 33.1% in the 2nd quarter. FMR LLC now owns 3,454,533 shares of the medical equipment provider’s stock worth $281,544,000 after acquiring an additional 859,228 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Steris by 53.2% in the 2nd quarter. State Street Corp now owns 2,336,074 shares of the medical equipment provider’s stock worth $190,392,000 after acquiring an additional 811,622 shares during the last quarter. Hedge funds and other institutional investors own 89.45% of the company’s stock.
In other Steris news, insider Michael J. Tokich sold 11,000 shares of the stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $92.00, for a total value of $1,012,000.00. Following the sale, the insider now directly owns 58,588 shares of the company’s stock, valued at approximately $5,390,096. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total transaction of $905,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,650 shares of company stock worth $3,315,200. 2.55% of the stock is owned by insiders.
Shares of Steris PLC (STE) traded down $0.29 on Friday, reaching $88.45. 317,878 shares of the company traded hands, compared to its average volume of 243,949. Steris PLC has a 1 year low of $65.26 and a 1 year high of $93.39. The stock has a market cap of $7,547.55, a P/E ratio of 22.87 and a beta of 1.27. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.18 and a current ratio of 2.80.
Steris (NYSE:STE) last announced its earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share for the quarter, missing the consensus estimate of $0.95 by ($0.01). Steris had a return on equity of 11.49% and a net margin of 5.59%. The business had revenue of $634.20 million for the quarter, compared to analysts’ expectations of $629.02 million. During the same period in the previous year, the company earned $0.89 earnings per share. Steris’s quarterly revenue was down 1.9% on a year-over-year basis. research analysts predict that Steris PLC will post 4.06 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 20th. Investors of record on Wednesday, November 22nd will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.40%. The ex-dividend date is Tuesday, November 21st. Steris’s payout ratio is currently 73.81%.
STE has been the topic of several recent analyst reports. KeyCorp restated an “overweight” rating and issued a $101.00 price objective (up from $91.00) on shares of Steris in a report on Thursday, November 2nd. Zacks Investment Research lowered shares of Steris from a “buy” rating to a “sell” rating in a report on Monday, November 6th. TD Securities upped their target price on shares of Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research note on Thursday, November 9th. Finally, Raymond James Financial upped their target price on shares of Steris from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $79.50.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/09/steris-plc-ste-stake-lowered-by-atlanta-capital-management-co-l-l-c.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris PLC and related companies with MarketBeat.com's FREE daily email newsletter.